Two River Bancorp Reports 47.6% Increase in Fourth Quarter Net Income and Record 2016 Annual Results
Jan 25, 2017 13:01 pm UTC| Business
TINTON FALLS, N.J., Jan. 25, 2017 -- Two River Bancorp (Nasdaq:TRCB) (the "Company"), the parent company of Two River Community Bank ("the Bank"), today reported financial results for the fourth quarter and twelve...
Post Holdings Schedules First Quarter Fiscal Year 2017 Conference Call
Jan 25, 2017 13:01 pm UTC| Business
ST. LOUIS, Jan. 25, 2017 -- Post Holdings, Inc. (NYSE:POST), a consumer packaged goods holding company, today announced it will host a conference call on Friday, February 3, 2017 at 9:00 a.m. Eastern Time to discuss...
Post Holdings Schedules First Quarter Fiscal Year 2017 Conference Call
Jan 25, 2017 13:01 pm UTC| Business
ST. LOUIS, Jan. 25, 2017 -- Post Holdings, Inc. (NYSE:POST), a consumer packaged goods holding company, today announced it will host a conference call on Friday, February 3, 2017 at 9:00 a.m. Eastern Time to discuss...
SpotX Promotes Sean Buckley to Chief Revenue Officer
Jan 25, 2017 13:01 pm UTC| Business
DENVER, Jan. 25, 2017 -- SpotX today announced the promotion of Sean Buckley to Chief Revenue Officer. In the newly created role, Buckley will continue to lead SpotX’s Platform and Demand Facilitation teams, while...
SpotX Promotes Sean Buckley to Chief Revenue Officer
Jan 25, 2017 13:01 pm UTC| Business
DENVER, Jan. 25, 2017 -- SpotX today announced the promotion of Sean Buckley to Chief Revenue Officer. In the newly created role, Buckley will continue to lead SpotX’s Platform and Demand Facilitation teams, while...
DLH to Announce First Quarter FY17 Financial Results
Jan 25, 2017 13:00 pm UTC| Business
ATLANTA, Jan. 25, 2017 -- DLH Holdings Corp. (NASDAQ:DLHC) (“DLH” or the “Company”), a leading healthcare and human services provider to the Federal Government, today announced that it will release itsfirst quarter...
Neovacs Reports First Positive Immunogenicity Results for IFNα Kinoid in Model of Type 1 Diabetes
Jan 25, 2017 13:00 pm UTC| Business
PARIS and BOSTON, Jan. 25, 2017 -- Neovacs (Alternext Paris: ALNEV), a leader in active immunotherapies for the treatment of autoimmune diseases, today announced the recommendation of its Scientific Advisory Board to...